Regeneron Pharmaceuticals, Inc.
COMPOSITIONS AND METHODS FOR TREATING CYTOKINE RELEASE SYNDROME
Last updated:
Abstract:
The present invention provides compositions and methods for treating cancer and inhibiting cytokine release syndrome (CRS). The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a CD40 antagonist or a CAR-T cell expressing a CD40 antagonist in combination with a therapeutically effective amount of a CD3 multispecific antigen binding molecule.
Status:
Application
Type:
Utility
Filling date:
28 Jan 2022
Issue date:
28 Jul 2022